Real World Strategies for LDL-Mediated CV Risk in High Risk Patients Requiring LDL Reduction - Which Agents? In What Sequence? In Which Patient Subsets? A Case-Based Roadmap to Clinical Success - Karol E. Watson, MD, PhD, FACC